JOHN R MOORE
CIK 1191702 · General Counsel · last filed 2025-08-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$355.8K
Companies
2
Total Filings
53
Lifetime Open-Market Net
-$4.23M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EWTX | General Counsel | 10,214 | $34.83 | $355.8K | -$4.23M | 23 | 2025-08-14 |
| ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | Director | — | — | — | $0 | 2 | 2016-09-14 |
Recent Filings · Page 5 of 6
53 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-10-05 | — | Grant (A) | +11,886 | $0 | |
| 2012-04-03 | — | Grant (A) | — | $0 | |
| 2011-10-04 | — | Grant (A) | +28,547 | $0 | |
| 2011-04-05 | — | Sell (S) | −356 | -$1.2K | |
| 2011-04-05 | — | Grant (A) | — | $0 | |
| 2011-01-12 | — | Sell (S) | −2,959 | -$9.8K | |
| 2011-01-06 | — | Sell (S) | −24,039 | -$78.1K | |
| 2010-10-06 | — | Mixed | +6,037 | -$66.0K | |
| 2010-08-04 | — | Sell (S) | −6,319 | -$20.5K | |
| 2010-04-01 | — | Grant (A) | — | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.